Trends in Preoperative Chemotherapy Utilization for Proximal Pancreatic Cancer: Are We Making Progress?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Surgery
Link
https://link.springer.com/content/pdf/10.1007/s11605-022-05336-7.pdf
Reference25 articles.
1. Verma V, Li J, Lin C. Neoadjuvant therapy for pancreatic cancer. American journal of clinical oncology. 2016;39(3):302–13.
2. Dhir M, Zenati MS, Hamad A, Singhi AD, Bahary N, Hogg ME et al. FOLFIRINOX versus gemcitabine/nab-paclitaxel for neoadjuvant treatment of resectable and borderline resectable pancreatic head adenocarcinoma. Annals of surgical oncology. 2018;25(7):1896–903.
3. Motoi F, Kosuge T, Ueno H, Yamaue H, Satoi S, Sho M et al. Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05). Japanese journal of clinical oncology. 2019;49(2):190–4.
4. O’Reilly EM, Perelshteyn A, Jarnagin WR, Schattner M, Gerdes H, Capanu M et al. A single-arm, non-randomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma. Annals of surgery. 2014;260(1):142.
5. Maurel J, Sánchez-Cabús S, Laquente B, Gaba L, Visa L, Fabregat J et al. Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine–erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10–03 trial). Cancer chemotherapy and pharmacology. 2018;82(6):935–43.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. ASO Author Reflections: The More We See the More We are Capable of Seeing: Optimal Minimally Invasive Management of de Novo Pancreas Cancer After Prior Laparoscopic Whipple for Pancreas Cancer;Annals of Surgical Oncology;2024-07-22
2. Laparoscopic Total Pancreatectomy After Laparoscopic Whipple;Annals of Surgical Oncology;2024-07-03
3. Comparison Between Plastic and Metallic Biliary Stent Placement for Preoperative Patients with Pancreatic Head Cancer: A Systematic Review and Meta-Analysis;Annals of Surgical Oncology;2023-11-11
4. National adoption of neoadjuvant chemotherapy: paradigm shift in the treatment of pancreatic cancer;HPB;2023-11
5. Pancreatic Cancer Health Disparity: Pharmacologic Anthropology;Cancers;2023-10-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3